Indian pharmaceutical company Dr. Reddy’s Laboratories Ltd. has become the first drug maker authorized to sell a generic version of the blockbuster drug Ozempic, according to Health Canada.

The regulator’s website was updated Tuesday afternoon to show that it issued a notice of compliance to Dr. Reddy’s that day to make an injectable form of semaglutide, the active ingredient in Ozempic and Wegovy.

Generic semaglutide became legal in Canada as of Jan. 5, but Health Canada did not approve any of the active applications from six drug makers until now.

Dr. Reddy’s has been selling generic semaglutide in India since it became legal there last month.